Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3.

Metalloproteinases (MMPs) and their natural inhibitors (TIMPs) contribute to the regulation of tumor microenvironment. Their expressions are deregulated in almost all human cancers. We report a novel approach to gene therapy of hepatocellular carcinoma (HCC), using repeated injections of DNA plasmids encoding the tissue inhibitors of metalloproteinases (TIMPs) TIMP-2 or TIMP-3, and a novel competent formulation of gene transfer based on nontoxic cationic cholesterol derivatives. The new gene delivery system was efficient in demonstrating the antitumor efficiency of TIMP-2 or TIMP-3 in inhibiting tumor growth of human HuH7 HCC cells xenografted into nude mice. We show, for the first time, an in vivo effect of TIMP-3 in delaying HCC tumor growth. No treatment-related toxicity was noted. An inhibition of angiogenesis and tumor necrosis accompanied the inhibitory effects of TIMP-2 or TIMP-3 on tumor expansion and invasion. We also report a bystander effect produced by transfected HuH7 tumor cells mixed with untransfected cells in 1:1 ratio in culture that resulted in killing 98% of cells within 96 h. In addition, the soluble forms of TIMP-2 and TIMP-3 expressed by transfected cells exerted a cytotoxic effect on untransfected HuH7 cell cultures. Taken together, these results demonstrate the potential efficacy of repeated treatment of secreted TIMP-2 and TIMP-3 for the design of nonviral gene therapy for hepatocarcinoma.
AuthorsPhuong-Lan Tran, Jean-Pierre Vigneron, David Pericat, Sylvie Dubois, Dominique Cazals, Martial Hervy, Yves A DeClerck, Claude Degott, Christian Auclair
JournalCancer gene therapy (Cancer Gene Ther) Vol. 10 Issue 6 Pg. 435-44 (Jun 2003) ISSN: 0929-1903 [Print] England
PMID12768188 (Publication Type: Journal Article)
Chemical References
  • 3-((N',N'-diguanidinoethylaminoethyl)carbamoyl)cholesterol
  • Antigens, CD34
  • Cations
  • Guanidines
  • Tissue Inhibitor of Metalloproteinase-3
  • Tissue Inhibitor of Metalloproteinase-2
  • DNA
  • Cholesterol
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Animals
  • Antigens, CD34 (biosynthesis)
  • Carcinoma, Hepatocellular (therapy)
  • Cations
  • Cell Line
  • Cell Line, Tumor
  • Cholesterol (analogs & derivatives, chemistry, metabolism)
  • DNA (metabolism)
  • Female
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Genetic Vectors
  • Guanidines (chemistry)
  • Humans
  • Immunoblotting
  • In Situ Nick-End Labeling
  • Kinetics
  • Liver Neoplasms (therapy)
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Plasmids (metabolism)
  • Time Factors
  • Tissue Inhibitor of Metalloproteinase-2 (genetics)
  • Tissue Inhibitor of Metalloproteinase-3 (genetics)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: